These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9147424)

  • 41. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania.
    Fawzi WW; Msamanga GI; Spiegelman D; Urassa EJ; McGrath N; Mwakagile D; Antelman G; Mbise R; Herrera G; Kapiga S; Willett W; Hunter DJ
    Lancet; 1998 May; 351(9114):1477-82. PubMed ID: 9605804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
    Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Labor, method of delivery and maternofetal transmission of HIV].
    Schäfer AP; Koch MA; Grosch-Wörner I; Friedmann W; Dudenhausen JW
    Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):617-22. PubMed ID: 8719004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal vitamin A status and mother-to-child transmission of HIV in West Africa. DITRAME Study Group.
    Castetbon K; Manigart O; Bonard D; Thomas MJ; Dumon MF; Malvy D; Van de Perre P; Dabis F
    AIDS; 2000 May; 14(7):908-10. PubMed ID: 10839607
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
    Gray GE; Urban M; Chersich MF; Bolton C; van Niekerk R; Violari A; Stevens W; McIntyre JA;
    AIDS; 2005 Aug; 19(12):1289-97. PubMed ID: 16052084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin A deficiency and other nutritional indices during pregnancy in human immunodeficiency virus infection: prevalence, clinical correlates, and outcome. Women and Infants Transmission Study Group.
    Burns DN; FitzGerald G; Semba R; Hershow R; Zorrilla C; Pitt J; Hammill H; Cooper ER; Fowler MG; Landesman S
    Clin Infect Dis; 1999 Aug; 29(2):328-34. PubMed ID: 10476737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin A and HIV infection: disease progression, mortality, and transmission.
    Kennedy CM; Kuhn L; Stein Z
    Nutr Rev; 2000 Oct; 58(10):291-303. PubMed ID: 11127968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection.
    Semba RD; Miotti PG; Chiphangwi JD; Liomba G; Yang LP; Saah AJ; Dallabetta GA; Hoover DR
    Clin Infect Dis; 1995 Oct; 21(4):966-72. PubMed ID: 8645848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Roongpisuthipong A; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Parekh B; Mock PA; Bhadrakom C; Chinayon P; Kalish ML; Phillips SK; Granade TC; Subbarao S; Weniger BG; Mastro TD
    J Infect Dis; 1999 Mar; 179(3):590-9. PubMed ID: 9952365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal vitamin A deficiency and infant mortality in Malawi.
    Semba RD; Miotti PG; Chiphangwi JD; Dallabetta G; Yang LP; Saah A; Hoover D
    J Trop Pediatr; 1998 Aug; 44(4):232-4. PubMed ID: 9718911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia.
    Ngoma MS; Misir A; Mutale W; Rampakakis E; Sampalis JS; Elong A; Chisele S; Mwale A; Mwansa JK; Mumba S; Chandwe M; Pilon R; Sandstrom P; Wu S; Yee K; Silverman MS
    J Int AIDS Soc; 2015; 18(1):19352. PubMed ID: 26140453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
    ; Andiman W; Bryson Y; de Martino M; Fowler M; Harris D; Hutto C; Korber B; Kovacs A; Landesman S; Lindsay M; Lapointe N; Mandelbrot L; Newell M-L; Peavy H; Read J; Rudin C; Semprini A; Simonds R; Tuomala R
    N Engl J Med; 1999 Apr; 340(13):977-87. PubMed ID: 10099139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for postnatal mother-child transmission of HIV-1.
    Embree JE; Njenga S; Datta P; Nagelkerke NJ; Ndinya-Achola JO; Mohammed Z; Ramdahin S; Bwayo JJ; Plummer FA
    AIDS; 2000 Nov; 14(16):2535-41. PubMed ID: 11101065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.
    O'Donovan D; Ariyoshi K; Milligan P; Ota M; Yamuah L; Sarge-Njie R; Whittle H
    AIDS; 2000 Mar; 14(4):441-8. PubMed ID: 10770548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Mock PA; Shaffer N; Bhadrakom C; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Roongpisuthipong A; Chinayon P; Kalish ML; Parekh B; Mastro TD
    AIDS; 1999 Feb; 13(3):407-14. PubMed ID: 10199232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.